Coactivation of innate immune suppressive cells induces acquired resistance against cancer immunotherapy targeting the innate immune system [TIICs RNA-seq]
RNA-seq (gene expression) · mouse · 30 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 30 samples: 10 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Coactivation of innate immune suppressive cells induces acquired resistance against combined TLR agonism and PD-1 blockadeScience translational medicine · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE281467_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1183892 and SRA study SRP544120. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 30 samples.
How we read this: 10 replicated groups read from 30 sample titles; they account for 30 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8621205 MC38_1 MC38
- GSM8621206 MC38_2 MC38
- GSM8621207 MC38_3 MC38
- GSM8621208 MC38OVA_1 MC38OVA
- GSM8621209 MC38OVA_2 MC38OVA
- GSM8621210 MC38OVA_3 MC38OVA
- GSM8621211 EMT6_1 EMT6
- GSM8621212 EMT6_2 EMT6
- GSM8621213 EMT6_3 EMT6
- GSM8621214 LL2_1 LL2
- GSM8621215 LL2_2 LL2
- GSM8621216 LL2_3 LL2
- GSM8621217 CT26_1 CT26
- GSM8621218 CT26_2 CT26
- GSM8621219 CT26_3 CT26
- GSM8621220 CT26NYESO1_1 CT26NYESO1
- GSM8621221 CT26NYESO1_2 CT26NYESO1
- GSM8621222 CT26NYESO1_3 CT26NYESO1
- GSM8621223 CMS5a_1 CMS5a
- GSM8621224 CMS5a_2 CMS5a
- GSM8621225 CMS5a_3 CMS5a
- GSM8621226 Renca_1 Renca
- GSM8621227 Renca_2 Renca
- GSM8621228 Renca_3 Renca
- GSM8621229 B16F1_1 B16F1
- GSM8621230 B16F1_2 B16F1
- GSM8621231 B16F1_3 B16F1
- GSM8621232 B16F10_1 B16F10
- GSM8621233 B16F10_2 B16F10
- GSM8621234 B16F10_3 B16F10
- GSE281466 Coactivation of innate immune suppressive cells induces acquired resistance against cancer immunotherapy targeting the innate immune system [TME RNA-seq] 18 samples shares immunotherapy, coactivation, suppressive, resistance, targeting, acquired, induces, against
- GSE275780 Dual Targeting of STING and PI3Kγ Eliminates Regulatory B Cells to Overcome STING Resistance for Pancreatic Cancer Immunotherapy [RNA-seq] 17 samples shares immunotherapy, resistance, targeting
- GSE261898 Acquired resistance to immunotherapy by physical barriers with cancer cell–expressing collagens in non–small cell lung cancer 14 samples shares immunotherapy, resistance, acquired
- GSE307773 Oncogenic MAPK signalling induces epithelial cell state change and therapeutic resistance in vivo [RNA-Seq] 175 samples shares resistance, induces
- GSE328461 Osteopontin mediates acquired resistance to hypoxia-inducing antiangiogenics and promotes anti-PD-L1 refractoriness in breast cancer models 37 samples shares resistance, acquired
- GSE307774 Oncogenic MAPK signalling induces epithelial cell state change and therapeutic resistance in vivo [scRNA-Seq] 29 samples shares resistance, induces
- GSE315303 Pygo2 Loss Induces Tertiary Lymphoid Structure Formation and Enhances Immunotherapy and Castration Responses in Prostate Cancer 22 samples shares immunotherapy, induces
- GSE284264 Spatial genomics reveals cholesterol metabolism as a key factor in immunotherapy resistance in colorectal cancer [bulk RNA-seq] 16 samples shares immunotherapy, resistance
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.